ArticleToxins2026
Ochratoxin A Toxicity Research in In Vitro and In Vivo Experimental Settings: A Cross-Software Bibliometric and Science-Mapping Study.
Article in Toxins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundOchratoxin A (OTA) is a widespread mycotoxin with well-established nephrotoxic, immunotoxic, and carcinogenic properties. Despite decades of research, the structure, thematic evolution, and emerging directions of the scientific literature on OTA toxicity remain incompletely mapped.
methodsA bibliometric analysis was conducted using 883 publications indexed in the Web of Science Core Collection (1965-2025). Bibliometrix, VOSviewer, and BibExcel were integrated within a comparative cross-software workflow to assess publication trends, collaboration networks, thematic evolution, and thematic research directions in in vitro and in vivo OTA toxicity studies, while enabling cross-validation of the main bibliometric outputs.
resultsAfter normalisation, authors, journals, author keywords, and Keywords Plus showed strong cross-software agreement, whereas country and institution outputs retained software dependent differences related mainly to country aggregation and affiliation parsing. Publication output increased substantially over the analysed period, particularly during the most recent decade, reflecting the growing visibility of OTA research in food safety and toxicology. The field is highly collaborative and multidisciplinary. Oxidative stress-related terms were prominent in the keyword and thematic analyses and co-occurred with terminology related to apoptosis, DNA damage, and mitochondrial dysfunction. Thematic evolution analyses showed a transition from early studies focused on nephrotoxicity and animal models toward more recent investigations addressing molecular pathways, cellular responses, and microbiota host interactions. Comparatively less prominent or emerging bibliometric themes included the gut immune axis, co-exposure to multiple mycotoxins, and the broader representation of animal-health and productivity-related research.
conclusionsThe bibliometric and science mapping analyses indicate that the literature on OTA toxicity has evolved from predominantly organ, and animal model-related research, toward increasing attention to molecular, cellular, intestinal, and microbiota-related topics. These patterns describe changes in the conceptual structure of the literature rather than direct evidence of biological causality. Comparatively, less prominent themes, including human-relevant models, combined exposure scenarios, and microbiome-related research, may warrant further investigation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.